You are here

ENMD-2076

EntreMed commences ENMD-2076 Phase 2 trial

The Fly on the Wall

Thu, 10/31/13 - 11:16 am

EntreMed announces initiation of phase 2 trial in triple-negative breast cancer

Yahoo/Fly on the Wall

Wed, 07/25/12 - 09:33 am

triple-negative breast cancer

EntreMed shares spike on PhII cancer data

Fierce Biotech

Mon, 10/3/11 - 11:42 am

EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients

Yahoo/PR NewsWire

Sat, 06/4/11 - 09:57 am

Six Trades on FDA, Clinical Trial Binary Events

Seeking Alpha

Tue, 07/13/10 - 09:14 pm

Protalix BioTherapeutics

cancer vaccines

EntreMed Raises Additional $3 Million to Further Support Clinical Development of ENMD-2076 in Ovarian Cancer

Yahoo/PR NewsWire

Sat, 04/17/10 - 12:20 pm

Aurora A/angiogenic kinase inhibitor